Unigestion Holding Sa Stryker Corp Transaction History

Unigestion Holding Sa

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$293.94 - $358.71 $471,773 - $575,729	1,605 New	1,605 $574,000
Q3 2023 Oct 31, 2023	SELL	$266.54 - $302.43 $283,332 - $321,483	-1,063 Reduced 55.98%	836 $228,000
Q2 2023 Jul 27, 2023	SELL	$271.49 - $305.09 $103,980 - $116,849	-383 Reduced 16.78%	1,899 $579,000
Q1 2023 May 09, 2023	SELL	$246.13 - $285.47 $232,346 - $269,483	-944 Reduced 29.26%	2,282 $651,000
Q4 2022 Feb 13, 2023	BUY	$205.51 - $253.93 $662,975 - $819,178	3,226 New	3,226 $788,000
Q4 2018 Feb 08, 2019	SELL	$145.0 - $178.65 $1.41 Million - $1.74 Million	-9,715 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$163.25 - $177.68 $11.7 Million - $12.7 Million	-71,685 Reduced 88.07%	9,715 $1.73 Million
Q2 2018 Jul 24, 2018	BUY	$155.17 - $179.78 $12.6 Million - $14.6 Million	81,400 New	81,400 $13.7 Million

2,171

286M

1.13M

1.1M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $136B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Unigestion Holding Sa, based on Form 13F filings with the SEC.

Stay updated on Unigestion Holding Sa with notifications on news.